Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | jaya enterprises | 4 | ₹6.0 L |
| 2 | Schedule 2 | jaya enterprises | 4 | ₹2.7 L |
| 3 | Schedule 3 | P.S.PHARMA | 4 | ₹1.8 L |
| 4 | Schedule 4 | jaya enterprises | 4 | ₹18.0 L |
| 5 | Schedule 5 | jaya enterprises | 4 | ₹45,000 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
18 Oct 2023, 8:00 pmClosed
Benzoin 500 ml (Q3)
69 Cholecalciferol Granules 60000 I. U. (Q3)
70 Steril Disp. Umbilical Cord Clamp (Q3)
71 Chromic Catgut
Chromic Catgut with needle 3/8 (Q3)
72 Chromic Catgut Size 2-0 Box of 12 Foils (Q3)
73 Surgical Blade
Surgical Blade (Q3)
74 Surgical Gloves Powder free (Sterile) (Q3)
75 Surgical Gloves Powder free (Sterile) (Q3)
77 Disposable Scalp Vein Set No. 23 Each (Q3)
78 Disposable Scalp Vein Set No. 24 each (Q3)
80 Ciprofloxacin+ Dexamethasone Eye Drops 5 ml (Q3)
81 Disposable syringe sterile with needle 1inch 10 ml (Q3)
82 Disposable syringe sterile with needle 1inch 5 ml (Q3)
83 Disposable syringe sterile with needle 1inch 2 ml (Q3)
84 Frusemide Inj.
Inj. Frusemide - 2 ml Each 1 mL (Q3)
88 Inj. Sodabicarbonate 7.5 mg/ml (7.5% ) - 10 ml (Q3)
89 Inj. Cefotaxim 1000 mg (Q3)
94 Inj. Promethazine 2 ml (Q3)
95 Inj. Iron sucrose 2.5 ml amp (Q3)
96 Dexamethasone Inj. 2 ml (Q3)
97 Gentamycin Inj. 40 mg/2 ml (Q3)
99 Cyanocobalamine Inj. 1000 mcg/ml 10 ml Vial (Q3)
101 Inj. Oxytocin 1 ml amp (Q3)
103 Ringer Lactate Inj.
I. V. RL 500 ml (Q3)
105 Metronidazole I. V Inj.
100 ml (Q3)
Tab. Azithromycin - 250 mg (Q3)
Amlodepin Tab
Tab. Amlodepin besylate 5 mg (Q3)
Tab. Amlodepin besylate 2.5 mg (Q3)
Tab. Salbutamol Sulphate 4 mg Aluminium Blister - Strip of 10 Tab (Q3)
Clotrimoxazole Vaginal Pessaries with applicator 100 mg (Q3)
Cough Expectorant Diphenhydramine hydrochloride 15 mg (IP) (Q3)
48 Syrup. Azithromycin 200 mg per 5 ml 15 ml Bottle (Q3)
Syrup. Amoxycillin Trihydrate 125 mg/5 ml- Bottle of 60 ml (Q3)
Amoxycillin+ Clavullinic acid dry Syp. 200 mg+ 28.5 mg/5 ml 30 ml (Q3)
58 Oral Rehydration Salt Powder WHO Formula 20.5 gms Sachet (Q3)
59 Adhesive Plaster cotton based(hypo allergic)
Adhesive plaster (Q3)
62 Disposable delivery kit
Disposable delivery kit -? High quality (Q3)
63 Makintosh Double Colour Water Proof Rubber Width- 90 cm (Q3)
64 Hydrogen peroxide IP
20 volume 6% w/v 500 ml (Q3)
66 Povidine lodine solution scrub 7.50% 500 ml[ 316.3 (Q3)
67 Gamma Benzene Hydrochloride lotion 100 ml (333.1) (Q3)
68 Iron & Folic Acid Drops 15 ml (Q3)
76 IV Sets with hypodermic needle 21G Of1.5 inch length Each (Q3)
79 Dichloronetaxinol+ Terpineol (Soap solution base)
(Q3)
85 Lignocaine HCL IP Inj. 2% 30 ml vial (Q3)
86 Hydrocortisone Sodium Succinate Inj.
Inj. HSS 100mg; (Q3)
87 Adrenaline Inj.
Inj. Epinephrine hydrochloride or hydrogen tartarate (Q3)
90 calcium gluconate Inj
Inj. Calcium Gluconate 100 mg/mL(w/v) 10 mL (Q3)
91 Inj. Pralidoxime chloride 1 gm (PAM)
Inj. Pralidoxime chloride 1g/20 ml (Q3)
92 Atropine Inj
Inj. Atropine sulphate0.6 mg/ml - 1 ml amp (Q3)
93 Pentazocine inj I. P
Inj. Pentazocin Lactate 30 mg/ml - 1 ml Ampoule (Q3)
98 AntiRabies Vaccine IM (Human Tissue Culture) 1 ml (Q3)
100 Ceftriaxone Inj. 1 gm Vial (Q3)
102 Dextrose with Normal Saline I. V 5% 500 ml Bottle (Q3)
104 Sodium Chloride - Normal Saline 0.9% Inj. I. V. NS
500 ml (Q3)
8 Azithromycin Tab. 500 mg (Q3)
14 Dexamethasone Tab.
Tab Dexamethasone 0.5 mg (Q3)
5239637
GEM/2023/B/3882669
Two Packet Bid
1 Cap. Amoxycillin -250 mg,2 Cap. Omeprazole 20 mg,Cap. Doxycyclin 100 mg,Amoxycillin+ Clavulanic A
30 days
Maharashtra; Ahmednagar
Item wise evaluation
PRODUCT_CUSTOM
11 documents required · 11 mandatory
1 yrs
₹3
20%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Benzoin 500 ml (Q3) | - | - | - |
| 69 Cholecalciferol Granules 60000 I. U. (Q3) | - | - | - |
| 70 Steril Disp. Umbilical Cord Clamp (Q3) | - | - | - |
| 71 Chromic Catgut | - | - | - |
| Chromic Catgut with needle 3/8 (Q3) | - | - | - |
| 72 Chromic Catgut Size 2-0 Box of 12 Foils (Q3) | - | - | - |
| 73 Surgical Blade | - | - | - |
| Surgical Blade (Q3) | - | - | - |
| 74 Surgical Gloves Powder free (Sterile) (Q3) | - | - | - |
| 75 Surgical Gloves Powder free (Sterile) (Q3) | - | - | - |
| 77 Disposable Scalp Vein Set No. 23 Each (Q3) | - | - | - |
| 78 Disposable Scalp Vein Set No. 24 each (Q3) | - | - | - |
| 80 Ciprofloxacin+ Dexamethasone Eye Drops 5 ml (Q3) | - | - | - |
| 81 Disposable syringe sterile with needle 1inch 10 ml (Q3) | - | - | - |
| 82 Disposable syringe sterile with needle 1inch 5 ml (Q3) | - | - | - |
| 83 Disposable syringe sterile with needle 1inch 2 ml (Q3) | - | - | - |
| 84 Frusemide Inj. | - | - | - |
| Inj. Frusemide - 2 ml Each 1 mL (Q3) | - | - | - |
| 88 Inj. Sodabicarbonate 7.5 mg/ml (7.5% ) - 10 ml (Q3) | - | - | - |
| 89 Inj. Cefotaxim 1000 mg (Q3) | - | - | - |
| 94 Inj. Promethazine 2 ml (Q3) | - | - | - |
| 95 Inj. Iron sucrose 2.5 ml amp (Q3) | - | - | - |
| 96 Dexamethasone Inj. 2 ml (Q3) | - | - | - |
| 97 Gentamycin Inj. 40 mg/2 ml (Q3) | - | - | - |
| 99 Cyanocobalamine Inj. 1000 mcg/ml 10 ml Vial (Q3) | - | - | - |
| 101 Inj. Oxytocin 1 ml amp (Q3) | - | - | - |
| 103 Ringer Lactate Inj. | - | - | - |
| I. V. RL 500 ml (Q3) | - | - | - |
| 105 Metronidazole I. V Inj. | - | - | - |
| 100 ml (Q3) | - | - | - |
| Tab. Azithromycin - 250 mg (Q3) | - | - | - |
| Amlodepin Tab | - | - | - |
| Tab. Amlodepin besylate 5 mg (Q3) | - | - | - |
| Tab. Amlodepin besylate 2.5 mg (Q3) | - | - | - |
| Tab. Salbutamol Sulphate 4 mg Aluminium Blister - Strip of 10 Tab (Q3) | - | - | - |
| Clotrimoxazole Vaginal Pessaries with applicator 100 mg (Q3) | - | - | - |
| Cough Expectorant Diphenhydramine hydrochloride 15 mg (IP) (Q3) | - | - | - |
| 48 Syrup. Azithromycin 200 mg per 5 ml 15 ml Bottle (Q3) | - | - | - |
| Syrup. Amoxycillin Trihydrate 125 mg/5 ml- Bottle of 60 ml (Q3) | - | - | - |
| Amoxycillin+ Clavullinic acid dry Syp. 200 mg+ 28.5 mg/5 ml 30 ml (Q3) | - | - | - |
| 58 Oral Rehydration Salt Powder WHO Formula 20.5 gms Sachet (Q3) | - | - | - |
| 59 Adhesive Plaster cotton based(hypo allergic) | - | - | - |
| Adhesive plaster (Q3) | - | - | - |
| 62 Disposable delivery kit | - | - | - |
| Disposable delivery kit -? High quality (Q3) | - | - | - |
| 63 Makintosh Double Colour Water Proof Rubber Width- 90 cm (Q3) | - | - | - |
| 64 Hydrogen peroxide IP | - | - | - |
| 20 volume 6% w/v 500 ml (Q3) | - | - | - |
| 66 Povidine lodine solution scrub 7.50% 500 ml[ 316.3 (Q3) | - | - | - |
| 67 Gamma Benzene Hydrochloride lotion 100 ml (333.1) (Q3) | - | - | - |
| 68 Iron & Folic Acid Drops 15 ml (Q3) | - | - | - |
| 76 IV Sets with hypodermic needle 21G Of1.5 inch length Each (Q3) | - | - | - |
| 79 Dichloronetaxinol+ Terpineol (Soap solution base) | - | - | - |
| (Q3) | - | - | - |
| 85 Lignocaine HCL IP Inj. 2% 30 ml vial (Q3) | - | - | - |
| 86 Hydrocortisone Sodium Succinate Inj. | - | - | - |
| Inj. HSS 100mg; (Q3) | - | - | - |
| 87 Adrenaline Inj. | - | - | - |
| Inj. Epinephrine hydrochloride or hydrogen tartarate (Q3) | - | - | - |
| 90 calcium gluconate Inj | - | - | - |
| Inj. Calcium Gluconate 100 mg/mL(w/v) 10 mL (Q3) | - | - | - |
| 91 Inj. Pralidoxime chloride 1 gm (PAM) | - | - | - |
| Inj. Pralidoxime chloride 1g/20 ml (Q3) | - | - | - |
| 92 Atropine Inj | - | - | - |
| Inj. Atropine sulphate0.6 mg/ml - 1 ml amp (Q3) | - | - | - |
| 93 Pentazocine inj I. P | - | - | - |
| Inj. Pentazocin Lactate 30 mg/ml - 1 ml Ampoule (Q3) | - | - | - |
| 98 AntiRabies Vaccine IM (Human Tissue Culture) 1 ml (Q3) | - | - | - |
| 100 Ceftriaxone Inj. 1 gm Vial (Q3) | - | - | - |
| 102 Dextrose with Normal Saline I. V 5% 500 ml Bottle (Q3) | - | - | - |
| 104 Sodium Chloride - Normal Saline 0.9% Inj. I. V. NS | - | - | - |
| 500 ml (Q3) | - | - | - |
| 8 Azithromycin Tab. 500 mg (Q3) | - | - | - |
| 14 Dexamethasone Tab. | - | - | - |
| Tab Dexamethasone 0.5 mg (Q3) | - | - | - |
Exempted
18 Oct 2023
27 Sept 2023
18 Oct 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5239637.pdf
GEM_BID
specification_2023-08-26-14-57-16_17a04cf3ac5e787802adbb7322cebdac.pdf
SPECIFICATION
specification_2023-08-26-15-20-59_ec439fcfa954c2daa3704e0ea7eceace.pdf
SPECIFICATION
specification_2023-08-26-14-58-23_4e50cba8935ca806baa5553cb065e457.pdf
SPECIFICATION
specification_2023-08-26-14-59-48_f47dee43f3a0695250dd4ba52ae42097.pdf
SPECIFICATION
specification_2023-08-26-15-01-08_64c3c5a99c0a329e5007c74baa51e30b.pdf
SPECIFICATION
specification_2023-08-26-15-02-18_670039230fde235c0ed63fa61a68089e.pdf
SPECIFICATION
specification_2023-08-26-15-07-25_abe1e8429d5c4ec2188e71cb0f90b9ab.pdf
SPECIFICATION
specification_2023-08-26-15-08-36_de30d8645af842f24a575ffbfdcf74cc.pdf
SPECIFICATION
specification_2023-08-26-15-09-13_b27997fa6059a62d2aa971a6cab841de.pdf
SPECIFICATION
specification_2023-08-26-15-10-09_a377d99baaa6b552282126ef73d446a7.pdf
SPECIFICATION
specification_2023-08-26-15-10-49_042afe67201a641865b851b263970558.pdf
SPECIFICATION
specification_2023-08-26-15-12-20_d7cfdc0390695491bbe91d2172c46bab.pdf
SPECIFICATION
specification_2023-08-26-15-12-52_b098df240502cc85288b65679137539e.pdf
SPECIFICATION
specification_2023-08-26-15-13-51_d121d541765e06a44eac962a2f1cbb94.pdf
SPECIFICATION
specification_2023-08-26-15-15-10_d74fb132ce5872120828b48755b8bcf4.pdf
SPECIFICATION
specification_2023-08-26-15-15-49_d1f0592350b63681133ddacdad888e3b.pdf
SPECIFICATION
specification_2023-08-26-15-16-34_480d7b1f5aedbb32b349a8a9ba0d74eb.pdf
SPECIFICATION
specification_2023-08-26-15-18-15_6d4fd79154ac1506628f0a4757720ee5.pdf
SPECIFICATION
specification_2023-08-26-15-19-25_ad1d56da8f1a76788a1d5f482f3afd9b.pdf
SPECIFICATION
specification_2023-08-26-15-20-09_671446c9b91a0cc159dd79752cef6222.pdf
SPECIFICATION
specification_2023-08-26-16-04-57_7f04f0f13b34f6cc8a08cd88a0099b23.pdf
SPECIFICATION
specification_2023-08-26-16-05-44_011d00f6f60ab241461f4d421cf11877.pdf
SPECIFICATION
specification_2023-08-26-16-06-16_da3254974ca70e86b677b8e20bd76c70.pdf
SPECIFICATION
specification_2023-08-26-16-07-09_b6340c9eac5e237c35dcb947530f84ac.pdf
SPECIFICATION
specification_2023-08-26-16-08-23_cdd46422d10001c757c4a0de5e55042c.pdf
SPECIFICATION
specification_2023-08-26-16-09-33_2f3c7167722b2265c48bad907d42602e.pdf
SPECIFICATION
specification_2023-08-26-16-11-28_e34cc24c0319b3bf5147bed6691fb537.pdf
SPECIFICATION
specification_2023-08-26-16-12-13_f89bf7774de50e4db9596e7074901c56.pdf
SPECIFICATION
specification_2023-08-26-16-13-16_52e833fbdb0d00c403c78d5465814c88.pdf
SPECIFICATION
specification_2023-08-26-16-13-46_b4d24f0d8cfa91f5e8c7334d9386903e.pdf
SPECIFICATION
specification_2023-08-26-16-14-28_af51f796f06c31efdaeaadc7ea89f4e3.pdf
SPECIFICATION
specification_2023-08-26-16-16-08_5fef807ddd2dc20105624235ac6fd198.pdf
SPECIFICATION
specification_2023-08-26-16-16-48_eee9545d884f05ee059b1242fc4506a3.pdf
SPECIFICATION
specification_2023-08-26-16-20-55_723fbfa6e4e3a6abda3dc7120be3bb69.pdf
SPECIFICATION
specification_2023-08-26-16-22-06_7d0c5850b74a98cc5d542349f75677d2.pdf
SPECIFICATION
specification_2023-08-26-16-23-06_bcaf7a91041708f865657077d5ea136e.pdf
SPECIFICATION
specification_2023-08-26-16-24-10_341c47a0e23d9376dd4610bfe78de15c.pdf
SPECIFICATION
specification_2023-08-26-16-25-40_495a441a091e29d584d271ee7c4f1ab1.pdf
SPECIFICATION
specification_2023-08-26-16-27-07_0cb325fbf2d11e6562a64776cb5d4064.pdf
SPECIFICATION
specification_2023-08-26-16-28-15_76346a3e65c293672d5c6267a4530654.pdf
SPECIFICATION
specification_2023-08-26-17-06-33_98bb0e9ff9e4e2df4a96ed42d3d64403.pdf
SPECIFICATION
specification_2023-08-26-17-07-37_a78abdd2ae506119bd136a98cd6734c4.pdf
SPECIFICATION
specification_2023-08-26-17-09-00_ef3a04f437c0bbd49b5eb25a727a27c8.pdf
SPECIFICATION
specification_2023-08-26-17-10-09_9d1eff7dcc431bd62cac4489f8ca8ee2.pdf
SPECIFICATION
specification_2023-08-26-17-05-10_0f3bafc912afd5119c83a615af363a10.pdf
SPECIFICATION
specification_2023-08-26-17-03-51_9b8d3e3243d3a4f71c2e0a82039d9c39.pdf
SPECIFICATION
specification_2023-08-26-17-02-54_de671fedeb967a0989fb5e0036babf41.pdf
SPECIFICATION
specification_2023-08-26-17-02-15_ae85c8c151ce279cb8c499ce74511292.pdf
SPECIFICATION
specification_2023-08-26-17-01-23_7ede83c77227666c46cb6eeb91fafabe.pdf
SPECIFICATION
specification_2023-08-26-17-00-10_e5033fdc2a0107f7d9978ad46c058b76.pdf
SPECIFICATION
specification_2023-08-26-16-58-40_7e68ce53fdc1d919fdeadbee69721c60.pdf
SPECIFICATION
specification_2023-08-26-16-55-31_7f037e8ddc15284c5d26a807c6d67def.pdf
SPECIFICATION
specification_2023-08-26-16-54-31_5b74a909eb49970faf251c5420555317.pdf
SPECIFICATION
specification_2023-08-26-16-53-30_5ff08e13a67fc7ba0abe12412b7feaf1.pdf
SPECIFICATION
specification_2023-08-26-16-52-02_c344b87ee320a4d030faae6cb6f1e122.pdf
SPECIFICATION
specification_2023-08-26-16-51-29_0e9024e6537712da76690bfa0418d6f3.pdf
SPECIFICATION
specification_2023-08-26-16-50-38_fed049dcb883f3ed79011b6aa2a45bd8.pdf
SPECIFICATION
specification_2023-08-26-16-49-25_02aa8baf76d39b16f8c164e8d9574295.pdf
SPECIFICATION
specification_2023-08-26-16-48-14_b8eab388044240f447a73727e7101005.pdf
SPECIFICATION
specification_2023-08-26-16-47-08_57c24be42ad5e1f9162787978b179bb9.pdf
SPECIFICATION
specification_2023-08-26-16-45-55_ce6579575ced8bbd178315e2393a6563.pdf
SPECIFICATION
specification_2023-08-26-16-45-10_31bff9ec5dcb5daf6ec25288d359b8a2.pdf
SPECIFICATION
specification_2023-08-26-16-44-01_ebbf0930230ecb7b92fccbb49231eebd.pdf
SPECIFICATION
specification_2023-08-26-16-42-56_caba8b6b2ef680982cd002ea88116cc8.pdf
SPECIFICATION
specification_2023-08-26-16-41-49_d221832ebd57bcbe5728694a46870d23.pdf
SPECIFICATION
specification_2023-08-26-16-38-29_05f519fbfb4249ca115ee4fab40be112.pdf
SPECIFICATION
specification_2023-08-26-16-37-29_17c4817d031fe34b680653840b89f77f.pdf
SPECIFICATION
specification_2023-08-26-16-36-20_8348563278fa20d436f8dc0c00544251.pdf
SPECIFICATION
specification_2023-08-26-16-35-28_e9a180b366781f7441d2524a8a3d5b39.pdf
SPECIFICATION
specification_2023-08-26-16-33-42_a1daae25d082e569cc4c0f91865ae0f9.pdf
SPECIFICATION
specification_2023-08-26-16-32-53_933c93907529fd9e21ed5b0aa87adb9d.pdf
SPECIFICATION
specification_2023-08-26-16-31-58_ec45f0d886e41c2048633596c1c37218.pdf
SPECIFICATION
specification_2023-08-26-16-30-53_05916efc9b5d1b0e0025f48c2818c6b6.pdf
SPECIFICATION
specification_2023-08-26-14-40-59_202201d17423ea3435647ca28536d227.pdf
SPECIFICATION
specification_2023-08-26-17-12-33_09a9bbc8ea937e2bbc24ce8bdf0f4b45.pdf
SPECIFICATION
specification_2023-08-26-17-13-35_e77275d41a4b20049cb33efea3daf019.pdf
SPECIFICATION
specification_2023-08-26-17-18-15_9ffa4f124783554a50fa8901d77f1965.pdf
SPECIFICATION
specification_2023-08-26-17-20-25_35498d24dd55250acd61dcda66ba67d3.pdf
SPECIFICATION
specification_2023-08-26-17-25-10_40975c8d4745326b8e717e4bdca1ea45.pdf
SPECIFICATION
specification_2023-08-27-14-40-40_7617bfe345131f1c7561331eabe55812.pdf
SPECIFICATION
specification_2023-08-27-14-41-28_8227b71fb8c6a9433e65a20ec8c29722.pdf
SPECIFICATION
specification_2023-08-27-14-42-32_b9aa146e7277d8f80ea8d1d02b2ae2f6.pdf
SPECIFICATION
specification_2023-08-27-14-44-07_5921a91b93ba7789132d61a7018bac1a.pdf
SPECIFICATION
specification_2023-08-27-14-45-47_55a36f578e7479e11cf05cfd73fd1e2a.pdf
SPECIFICATION
specification_2023-08-27-14-47-33_0b1792fed838d9bc31661957064cec4e.pdf
SPECIFICATION
specification_2023-08-27-14-49-04_5591cab59385555f414e355ca87cf320.pdf
SPECIFICATION
specification_2023-08-27-14-51-05_01797b6511af91b389fc63d0081e8b20.pdf
SPECIFICATION
specification_2023-08-27-14-52-23_2b564217b9e8bef3d28839ee963236e2.pdf
SPECIFICATION
specification_2023-08-27-14-57-46_f251eec2f697fa25c09fa518f7ac5a46.pdf
SPECIFICATION
specification_2023-08-27-14-58-50_fa435b23457354f0240b353efa74c27e.pdf
SPECIFICATION
specification_2023-08-27-15-00-41_1b153f67b6a83173d6806cc4d8acad88.pdf
SPECIFICATION
specification_2023-08-27-15-02-03_3f268bbe0e44d3256fe81efea50dedb6.pdf
SPECIFICATION
specification_2023-08-27-15-06-08_ff3f83b80d3c796b7f8a5d871564e6f3.pdf
SPECIFICATION
specification_2023-08-27-15-06-55_97e33daecc336d240c677b72ef130d4d.pdf
SPECIFICATION
specification_2023-08-27-15-07-56_fdfa3908db91c914219b9f7725afcb9d.pdf
SPECIFICATION
specification_2023-08-27-15-08-43_b7a65071bc72b0d8ea3fc1834b5b0533.pdf
SPECIFICATION
specification_2023-08-27-15-10-39_49748636b83cc99589a541e9b1e06c96.pdf
SPECIFICATION
specification_2023-08-27-15-12-05_8079d0292cd465fa5ea4f8f64592863d.pdf
SPECIFICATION
specification_2023-08-27-15-13-00_07e469c7fddf28bb025fcea4bfc84290.pdf
SPECIFICATION
specification_2023-08-27-15-16-07_2d34833d2cf8570d19c830de078018da.pdf
SPECIFICATION
specification_2023-08-27-15-17-40_d6a2d6986e4a098dd9b2bb4e53570764.pdf
SPECIFICATION
specification_2023-08-27-15-19-20_328c0ca9fc96c22a2f160e48931083f5.pdf
SPECIFICATION
specification_2023-08-27-15-20-57_a6f2bc7547623719b86f9058b607cec2.pdf
SPECIFICATION
specification_2023-08-28-11-19-25_83320859fd77c256b64c1dea6777e97c.pdf
SPECIFICATION
specification_2023-08-28-11-20-20_313dc3aaabbd568a3a6ce479317804ce.pdf
SPECIFICATION
ATC_6b9958b9-07f7-4365-811d1695810719750_health.zpnagar.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .